Clinical Research, Pharma & Healthcare FinancingDevonian Reports Positive Results in MASH Liver StudyBusiness WireFebruary 14, 2025July 7, 2025 by Business WireFebruary 14, 2025July 7, 20250126 Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory diseases, today...
